|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for credit losses | |||||
| Deferred income tax provision (benefit) | |||||
| Stock-based compensation expense | |||||
| Gain on disposition of joint venture | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts payable and accrued expenses | |||||
| Income taxes payable | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Business acquisitions, net of cash acquired | |||||
| Proceeds from disposition of joint venture | |||||
| Capital expenditures | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings | |||||
| Repayments of debt | |||||
| Purchases of treasury stock | |||||
| Exercise of stock options | |||||
| Employee payroll tax withholdings on stock issued under stock-based compensation plans | |||||
| Dividends paid | |||||
| Distributions to noncontrolling interest partners | |||||
| Other financing activities, net | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of year | |||||
| Cash and cash equivalents and restricted cash, end of year | |||||
Loading...